Semnur Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.1	0.02	0.01	0.01	0.03
Cash & Short-Term Investments	0.1	0.02	0.01	0.01	0.03
Cash Growth	1371.43%	66.67%	-	-57.14%	-
Prepaid Expenses	1.12	0.58	0	0	0.05
Other Current Assets	-	-	5.98	-	-
Total Current Assets	1.22	0.6	6	0.01	0.07
Property, Plant & Equipment	0.75	0.75	0.69	0.69	0.69
Total Assets	1.97	1.35	6.68	0.7	0.76
Accounts Payable	6.42	5.91	-	-	-
Accrued Expenses	1.19	0.74	0.04	0.9	0.17
Short-Term Debt	2.77	3.52	-	-	-
Other Current Liabilities	-	-	-	-	0.02
Total Current Liabilities	10.38	10.17	0.04	0.9	0.2
Long-Term Debt	16.92	11.93	49.43	37.9	35.4
Total Liabilities	27.3	22.1	49.47	38.8	35.6
Common Stock	0.02	0.02	0.02	0	0
Additional Paid-In Capital	255.03	255.03	72.58	72.6	72.6
Retained Earnings	-280.38	-275.8	-115.38	-110.69	-107.43
Total Common Equity	-25.33	-20.75	-42.78	-38.09	-34.83
Shareholders' Equity	-25.33	-20.75	-42.78	-38.09	-34.83
Total Liabilities & Equity	1.97	1.35	6.68	0.7	0.76
Total Debt	19.68	15.45	49.43	37.9	35.4
Net Cash (Debt)	-19.58	-15.43	-49.42	-37.89	-35.37
Net Cash Per Share	-0.09	-0.08	-0.25	-0.24	-0.22
Filing Date Shares Outstanding	230.21	230.21	160	160	160
Total Common Shares Outstanding	230.21	230.21	160	160	160
Working Capital	-9.16	-9.57	5.96	-0.88	-0.12
Book Value Per Share	-0.11	-0.09	-0.27	-0.24	-0.22
Tangible Book Value	-25.33	-20.75	-42.78	-38.09	-34.83
Tangible Book Value Per Share	-0.11	-0.09	-0.27	-0.24	-0.22
Machinery	0.03	0.03	0.03	0.03	0.03
Construction In Progress	0.75	0.75	0.69	0.69	0.69